Search Results - "Chernovsky, Maria"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Gastrointestinal Manifestations of Sarcoidosis: A State-of-the-Art, Comprehensive Review of the Literature—Practical Clinical Insights and Many Unmet Needs on Diagnosis and Treatment.

    Authors: Nicolosi, Salvatore Chernovsky, Maria Angoni, Darina et al.

    Source: Pharmaceuticals (14248247). Sep2024, Vol. 17 Issue 9, p1106. 16p.

    HTML Full Text PDF Full Text
    Save to List
  2. 2

    Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-World Observation on Efficacy and Safety, Focus on Patients Undergoing Antithrombotic and Anticoagulant.

    Authors: Reccardini, Nicolò Chernovsky, Maria Salton, Francesco et al.

    Source: Pharmaceuticals (14248247). Jul2024, Vol. 17 Issue 7, p930. 12p.

    HTML Full Text PDF Full Text
    Save to List
  3. 3

    Safety of Nintedanib in a Patient with Chronic Pulmonary Fibrosis and Kidney Disease.

    Authors: Maggisano, Marta Mondini, Lucrezia Chernovsky, Maria et al.

    Source: Pharmaceuticals (14248247). Sep2024, Vol. 17 Issue 9, p1147. 9p.

    HTML Full Text PDF Full Text
    Save to List
  4. 4

    The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis.

    Authors: Kette, Stefano Reccardini, Nicolò Salton, Francesco et al.

    Source: Pharmaceuticals (14248247). Mar2025, Vol. 18 Issue 3, p411. 18p.

    HTML Full Text PDF Full Text
    Save to List
  5. 5

    First evaluation of microvascular damage through nailfold capillaroscopy of an uncommon case of Raynaud's phenomenon in multiple sclerosis: Case report and literature review.

    Authors: Mondini, Lucrezia Screm, Gianluca Salton, Francesco et al.

    Source: Clinical Hemorheology & Microcirculation. Aug2025, Vol. 90 Issue 4, p185-190. 6p.

    Save to List
  6. 6

    Comorbidities' Effect on IPF: Pathogenesis and Management.

    Authors: Salotti A Chianese M Romallo A et al.

    Source: Biomedicines [Biomedicines] 2025 Jun 01; Vol. 13 (6). Date of Electronic Publication: 2025 Jun 01.

    Publication Type: Journal Article; Review

    Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  7. 7

    Alveolar nitric oxide concentration as a potential biomarker of fibrosis and active disease in pulmonary sarcoidosis: a pilot study.

    Authors: Levra S Giannoccaro F Chernovsky M et al.

    Source: Journal of breath research [J Breath Res] 2025 Jan 29; Vol. 19 (2). Date of Electronic Publication: 2025 Jan 29.

    Publication Type: Journal Article

    Journal Info: Publisher: IOP Pub Country of Publication: England NLM ID: 101463871 Publication Model: Electronic Cited Medium: Internet ISSN: 1752-7163 (Electronic) Linking ISSN: 17527155 NLM ISO Abbreviation: J Breath Res Subsets: MEDLINE

    Save to List

Search Tools: